Could zinc oxide tetrapod nanoparticles be used as an effective immunotherapy against HSV-2?

Nanomedicine (Lond). 2016 Sep;11(17):2239-42. doi: 10.2217/nnm-2016-0249. Epub 2016 Aug 16.

Authors

Tejabhiram Yadavalli¹, Deepak Shukla^{1

2}

Affiliations

¹ Department of Ophthalmology and Visual Sciences, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
² Department of Microbiology & Immunology, College of Medicine, University of Illinois at Chicago, 1855 West Taylor Street, Chicago, IL 60612, USA.

PMID: 27527812
DOI: 10.2217/nnm-2016-0249

No abstract available

Keywords: herpes simplex virus; immunotherapy; microbivac; virus entry; zinc oxide nanoparticles.

Publication types

Editorial

MeSH terms

Animals
Antiviral Agents / pharmacology
Antiviral Agents / therapeutic use*
Cell Line
Herpes Genitalis / drug therapy*
Herpes Genitalis / immunology
Herpes Genitalis / virology
Herpesvirus 2, Human / drug effects*
Herpesvirus 2, Human / immunology
Herpesvirus Vaccines / immunology
Humans
Immunotherapy
Metal Nanoparticles / chemistry*
Surface Properties
Vaccination / methods
Zinc Oxide / chemistry*

Substances

Antiviral Agents
Herpesvirus Vaccines
Zinc Oxide